NLS SwedenBIO

On Wednesday, July 6th, SwedenBIO arranges a seminar on the subject: The return of the factories – This is how Sweden wins the battle for the future pharmaceutical production. The government has initiated a new industrial and export strategy, but is this enough in order to make Sweden a global leader within life science production […]

A government report on the future of life science in Sweden in part calls for strong academics, positive growth conditions for businesses and government support to sustain industry gains. The report, “A Competitive Ecosystem for Life Science,” is the result of meetings with 80 organizations and companies in Sweden’s life science sector and looks at […]

The three trade organizations LIF, Swedish Medtech and SwedenBIO have presented a common action plan for life science. The plan consists of 25 steps to strengthen Sweden’s competitiveness. For six months the trade organizations have worked to bring out the action plan which was presented on October 21. The organizations state that the Swedish government […]

Pharmaceutical company Orexo has received this year’s SwedenBIO Award. The award ceremony took place on May 20 during SwedenBIO’s annual meeting. The award was received by Peder Edman, Orexo’s Chief Scientific Officer. The jury’s motivation: “Orexo has during the year succeded in getting Zubsolv both approved and launched in the United States. Swedish life science companies […]

Ingrid Heath becomes the new Vice President of the organization as from March 18 this year. Heath has a background as a molecular biologist and journalist and has previously worked as Editor in Chief of Life Science Sweden and Läkemedelsvärlden. According to a statement from SwedenBIO Ingrid Heath will have operational responsibilities for policy issues […]

Swedish biotech company Affibody received this year’s SwedenBIO Award during SwedenBIO’s annual conference on May 21 in Stockholm. The jury’s motivation was that “Affibody has on a long-term basis established a well-functioning and successful business model. Affibody has unique technology platform as the basis of the development of protein drugs and imaging products, adapted for […]